| Income Statement for ONYX Pharmaceuticals Inc. (ONXX) | | | | | | | Income | in Thousands of Dollars | | | 12/2007 | 12/2006 | 12/2005 | 12/2004 | 12/2003 | | | Operating Revenue | - | 250 | 1,000 | 500 | - | | Adjustments to Revenue | - | - | - | - | - | | Cost of Revenue | 1,030 | 758 | 630 | 194 | 1,124 | | Gross Operating Profit | 1,030 | 1,008 | 1,630 | 694 | 1,124 | | | Selling/General/Admin Expense | (60,546) | (50,019) | (39,671) | (14,316) | (6,360) | | Research & Development | (25,413) | (30,980) | (63,120) | (35,846) | (33,638) | | EBITDA | (84,929) | (79,991) | (101,161) | (49,468) | (38,874) | | Depreciation & Amortization | (1,030) | (758) | (630) | (194) | (1,124) | | EBIT | (85,959) | (80,749) | (101,791) | (49,662) | (39,998) | | Interest Income | 19,256 | 11,983 | 6,242 | 3,164 | 834 | | Other Income, Net | - | - | 375 | - | (275) | | Total Income Avail For Interest Expense | (34,167) | (92,681) | (95,174) | (46,756) | (44,969) | | Interest Expense | - | - | - | - | - | | Pre-Tax Income | (34,167) | (92,681) | (95,174) | (46,756) | (44,969) | | Income Taxes | - | - | - | - | - | | Minority Interest | - | - | - | - | - | | Net Income from Continuing Operations | (34,167) | (92,681) | (95,174) | (46,756) | (44,969) | | Net Income from Discontinued Operations | - | - | - | - | - | | Net Income from Total Operations | (34,167) | (92,681) | (95,174) | (46,756) | (44,969) | | | Normalized Income | (34,167) | (92,681) | (95,174) | (46,498) | (39,439) | | Extraordinary Income | - | - | - | - | - | | Special Income/Charges | - | - | - | (258) | (5,530) | | Income from Cum. Effect of Acct Change | - | - | - | - | - | | Income from Tax Loss Carryforward | - | - | - | - | - | | Other Gains | - | - | - | - | - | | Total Net Income | (34,167) | (92,681) | (95,174) | (46,756) | (44,969) | | | Results | in Dollars (Preferred Dividends in Thousands) | | | 12/2007 | 12/2006 | 12/2005 | 12/2004 | 12/2003 | | | Dividends Paid Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | | Preferred Dividends | - | - | - | - | - | | | Basic EPS from Continuing Operations | -0.67 | -2.20 | -2.64 | -1.36 | -1.73 | | Basic EPS from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | | Basic EPS from Total Operations | -0.67 | -2.20 | -2.64 | -1.36 | -1.73 | | | Diluted EPS from Continuing Operations | -0.67 | -2.20 | -2.64 | -1.36 | -1.73 | | Diluted EPS from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | | Diluted EPS from Total Operations | -0.67 | -2.20 | -2.64 | -1.36 | -1.73 | | | |
